CoQ10 and endurance
Time on an exercise bicycle and oxygen consumption in CoQ10 studies.
Key points
- In physically active men, ubiquinol showed no convincing advantage in time on an exercise bicycle over six weeks. This trial does not establish longer performance on such a test. [1] See the evidence 1
- A review of studies in trained adults found no convincing advantage in maximal oxygen consumption. This measure characterizes an exercise test separately and is not the same as time on an exercise bicycle. [2] See the evidence 1
Practical guide
Check the conclusions and whether they apply to your situation.
Time to exhaustion and maximal oxygen consumption measure different aspects of exercise.
Key points
Why these conclusions
Two exercise measures
Healthy physically active men received 300 mg of ubiquinol daily or placebo for six weeks. Time on an exercise bicycle did not differ convincingly. [1]
A review of studies in trained healthy adults found no convincing advantage of CoQ10 in maximal oxygen consumption. The formulations, doses and durations varied. [2]
In physically active men, ubiquinol showed no convincing advantage in time on an exercise bicycle over six weeks.
| Parameter | Data |
|---|---|
| Result | In physically active men, ubiquinol showed no convincing advantage in time on an exercise bicycle over six weeks. No between-group difference was found after six weeks, interaction p=0.79; final analysis 26 and 25. |
| Participants | 54 healthy physically active men randomized |
| Form | Ubiquinol 300 mg/day |
| Dose | Ubiquinol 300 mg/day |
| Dose basis | Ubiquinol 300 mg/day |
| Comparator | Placebo |
| Duration | 6 weeks |
| Confidence | 2/4: Precision: Exact between-group confidence intervals were not extracted. Consistency: No grounds for a separate downgrade. Applicability to the specified group: The study tested the stated form, participant group and outcome. Possible publication bias: No specific data for a separate downgrade. Study methods: Some data missing; manufacturer involvement in the study. |
| Evidence base | 1 trial; outcome from the same participant group |
| Sources | [1] |
A review of studies in trained adults found no convincing advantage in maximal oxygen consumption.
| Parameter | Data |
|---|---|
| Result | A review of studies in trained adults found no convincing advantage in maximal oxygen consumption. SMD 0.03 (95% CI −0.32 to 0.39). |
| Participants | Trained healthy adults, 7 papers, 8 comparisons |
| Form | Oral CoQ10; formulations varied |
| Dose | Different doses across studies |
| Dose basis | Different doses across studies |
| Comparator | Control or placebo in RCTs |
| Duration | Durations varied |
| Confidence | 1/4: Precision: Small samples, intervals and uncertain clinical significance. Consistency: Insufficient data for a separate downgrade. Applicability to the specified group: The stated form, outcome, clinical context and population limit transferability. Possible publication bias: Insufficient data for a separate downgrade. Study methods: Limitations in assessing design, reporting or losses. |
| Evidence base | 7 studies for this outcome in the review |
| Sources | [2] |
Sources
- Effect of six weeks ubiquinol supplementation on mitochondrial respiratory function and exercise capacity in healthy males. https://pubmed.ncbi.nlm.nih.gov/42249931/
- The effects of coenzyme Q10 supplementation on exercise-induced oxidative stress and related physiological outcomes in athletes: a systematic review and meta-analysis. https://pubmed.ncbi.nlm.nih.gov/42798689/
Methodology: Subpages evidence-led supplement pipeline v1